Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish | New

SAN DIEGO–(BUSINESS WIRE)–July 27, 2022–

Dexcom, Inc. (NASDAQ: DXCM), the world leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of the Dexcom G6 mobile app in Spanish, available immediately to users with a compatible iOS (v1.10.1) or Android (v1.10.0) smart device.

This press release is multimedia. See the full version here: https://www.businesswire.com/news/home/20220727005109/en/

Dexcom Warrior Julie shows off the new Dexcom G6 mobile app in Spanish (Photo: Business Wire)

Diabetes disproportionately impacts Latinos, and as of 2022, an estimated 11.8% of Latino American adults have diagnosed diabetes. 1 Additionally, the CDC estimates that Latin American adults have a greater than 50% chance of developing type 2 diabetes, with an increased risk of complications. 2

“With a myriad of studies highlighting language barriers in healthcare leading to poor communication between patients and healthcare providers 3 and diminished quality of care and patient safety, providing access to diabetes information in the patient’s preferred language is important to improving health outcomes,” said Ana-Mari Calleja Carr, district sales manager at Dexcom, representing the South Florida region. “The launch of the Dexcom G6 app in Spanish is a positive step towards improving health equity for people with diabetes who speak primarily Spanish.”

To access the Dexcom G6 Mobile App in Spanish, users must install the latest version of the app and set the language of their compatible iOS (v1.10.1) or Android (v1.10.0)* smartphone to Spanish ( any dialect/region). The app will automatically display in Spanish as long as the phone language is set to Spanish.

“Being able to offer this powerful CGM technology to my Spanish-speaking patients in their preferred language can help them better understand their diabetes and be more proactive in managing their health,” said Dr. Rocio Harbison, MD, FACE, an endocrinologist who treats a large Spanish-speaking population. “CGM technology is one of the most powerful tools available for diabetes management and this new development from Dexcom will help improve access for Spanish-speaking people who often must manage their health with limited tools in Spanish.”

Dexcom G6 uses a small, wearable sensor and transmitter to continuously measure and wirelessly send glucose levels to a compatible smart device* or receiver, giving patients real-time glucose data without having to prick their finger. † The system also offers customizable alerts and alarms to help avoid potentially dangerous hypoglycemia and hyperglycemia events.

“It’s great to see that Dexcom has invested in developing a Spanish language app for patients,” said Siena Ruelas, professional soccer player and Dexcom Warrior with type 1 diabetes. a significant barrier to accessing important glucose information and improving one’s ability to make critical health decisions.”

The Dexcom Follow app is not immediately available in Spanish, but functionality will be added in a future product update. For more information in Spanish on Dexcom G6, please visit Dexcom.com/ayuda.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of diabetes through innovative Continuous Glucose Monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and parts of Asia/Oceania, Dexcom has established itself as a leader in diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom strives to simplify and improve diabetes management worldwide. For more information about Dexcom CGM, visit www.dexcom.com.

* For a list of compatible devices, visitwww.dexcom.com/compatibility.

If your glucose alerts and G6 readings do not match symptoms or expectations or if you are managing the maximum recommended dose of 1000 mg acetaminophen every 6 hours, use a blood glucose meter to make treatment decisions diabetes.

1https://www.diabetes.org/about-us/statistics/about-diabetes

2https://www.cdc.gov/diabetes/library/features/hispanic-diabetes.html

3https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201401/

© 2022 Dexcom, Inc. Dexcom, Dexcom G6 and Dexcom Follow are registered trademarks of DexCom, Inc. in the United States and may be registered in other countries. All rights reserved.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220727005109/en/

CONTACT: Media Contact

James McIntosh

619-884-2118

[email protected] Contact

Sean Christensen

858-203-6657

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: APPS/APPLICATIONS MOBILE/WIRELESS TECHNOLOGY MEDICAL DEVICES DIABETES HISPANIC SOFTWARE GENERAL HEALTH CONSUMER HEALTH

SOURCE: Dexcom, Inc.

Copyright BusinessWire 2022.

PUBLISHED: 07/27/2022 08:45 / DISK: 07/27/2022 08:46

http://www.businesswire.com/news/home/20220727005109/en

Copyright BusinessWire 2022.

Comments are closed.